Send to

Choose Destination
Drug Metab Dispos. 2018 Mar 7. pii: dmd.117.079384. doi: 10.1124/dmd.117.079384. [Epub ahead of print]

Expression of organic anion transporter 1 or 3 in human kidney proximal tubule cells reduces cisplatin sensitivity.

Author information

Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboudumc.
Div. Pharmacology, Utrecht Institute for Pharmaceutical Sciences.
Department of Physical Chemistry/Bioenergetics, Institute of Chemistry PC14, Technical University of.
Radboud University Medical Center


Cisplatin is a cytostatic drug used for treatment of solid organ tumors. The main adverse effect is organic cation transporter 2 (OCT2)-mediated nephrotoxicity, observed in 30% of patients. The contribution of other renal drug transporters is elusive. Here, cisplatin-induced toxicity was evaluated in human-derived proximal tubule epithelial cells (ciPTEC) expressing renal drug transporters, including OCT2 and organic anion transporter 1 (OAT1) or 3 (OAT3). Parent ciPTEC demonstrated OCT2-dependent cisplatin toxicity (TC50 34±1 μM after 24 h exposure), as determined by cell viability. Over-expression of OAT1 and OAT3 resulted in reduced sensitivity to cisplatin (TC50 45±6 μM and 64±11 μM after 24 h exposure, respectively). This effect was independent of OAT-mediated transport, as the OAT-substrates probenecid and diclofenac did not influence cytotoxicity. Decreased cisplatin sensitivity in OAT-expressing cells associated directly with a trend towards reduced intracellular cisplatin accumulation, explained by reduced OCT2 gene expression and activity. This was evaluated by Vmax of the OCT2-model substrate ASP+ (23.5±0.1 min-1, 13.1±0.3 min-1 and 21.6±0.6 min-1 in ciPTEC-parent, ciPTEC-OAT1 and ciPTEC-OAT3, respectively). While gene expression of cisplatin efflux transporter multidrug and toxin extrusion 1 (MATE1) was 16.2±0.3 fold upregulated in ciPTEC-OAT1 and 6.1±0.7 fold in ciPTEC-OAT3, toxicity was unaffected by the MATE substrate pyrimethamine, suggesting that MATE1 does not play a role in the current experimental set-up. In conclusion, OAT expression results in reduced cisplatin sensitivity in renal proximal tubule cells, explained by reduced OCT2-mediated uptake capacity. In vitro drug-induced toxicity studies should consider models that express both OCT and OAT drug transporters.


drug toxicity; kidney/renal


Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center